• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SISTEMAS MEDICOS ALARIS, S.A. DE C.V. ASSEMBLY NAC-Y SITE (0.088 TUBING) OEM; INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SISTEMAS MEDICOS ALARIS, S.A. DE C.V. ASSEMBLY NAC-Y SITE (0.088 TUBING) OEM; INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Catalog Number 8100-027
Device Problem Device Markings/Labelling Problem (2911)
Patient Problems No Patient Involvement (2645); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/20/2021
Event Type  malfunction  
Manufacturer Narrative
"date of event: unknown.The date received by manufacturer has been used for this field.Medical device expiration date: unknown.A device evaluation and/or device history review is anticipated, but is not complete.Upon completion, a supplemental report will be filed.Device manufacture date: unknown.(b)(4).
 
Event Description
It was reported that 1500 assembly nac-y site (0.088 tubing) oem had a mix of product types in a pack before use.The following was reported by the initial reporter: "mixed product.Customer was sent this lot 2 x's: (b)(4) pcs in oct 2020 ; (b)(4) pcs in dec 2020.".
 
Manufacturer Narrative
H6: investigation summary a 8100-027 sample was not required for investigation of this feedback as the customer provided photographs of the affected samples; analysis of the photographs confirmed the customer's experience with two different types of component identified within the bulk packaging.The details of this feedback were forwarded to the manufacturing site for investigation.They confirmed that it is possible that the mixed product occurred due to incorrect segregation of the two components following the assembly process; the segregation process is a manual procedure and is likely to have occurred due to human error.A review of the production records for lot 20108173 did not identify any in-process testing failures or quality deviations which may have resulted in a report of this nature.A review of the customer feedback database indicates that this is an isolated feedback with no further reports of this nature against the 8100-027 product in the past 12 months.
 
Event Description
It was reported that 1500 assembly nac-y site (0.088 tubing) oem had a mix of product types in a pack before use.The following was reported by the initial reporter: "mixed product - per the attached.Customer was sent this lot 2 x's: 60k pcs in oct 2020 ; 30k pcs in dec 2020.".
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ASSEMBLY NAC-Y SITE (0.088 TUBING) OEM
Type of Device
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
SISTEMAS MEDICOS ALARIS, S.A. DE C.V.
blvd. insurgentes no. 20351
parque industrial el florido
tijuana 22244
MX  22244
MDR Report Key11325375
MDR Text Key249051268
Report Number9616066-2021-50228
Device Sequence Number1
Product Code FPA
Combination Product (y/n)N
PMA/PMN Number
NA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,o
Type of Report Initial,Followup
Report Date 03/16/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/12/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number8100-027
Device Lot Number20108173
Was Device Available for Evaluation? No
Date Manufacturer Received03/16/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-